[HTML][HTML] Metabolic syndrome: a narrative review from the oxidative stress to the management of related diseases

G Martemucci, G Fracchiolla, M Muraglia, R Tardugno… - Antioxidants, 2023 - mdpi.com
Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide,
especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia …

[HTML][HTML] NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care

P Portincasa - Internal and Emergency Medicine, 2023 - Springer
The term non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common
type of chronic liver disease. NAFLD points to excessive hepatic fat storage and no evidence …

[HTML][HTML] Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian Region: a meta-analysis

MA Niriella, DS Ediriweera, MY Withanage… - The Lancet Regional …, 2023 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is the commonest chronic liver
disease worldwide. We estimated the prevalence and predefined associated factors for …

[HTML][HTML] Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease

S Kotlyarov - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
In recent years, there has been a steady growth of interest in non-alcoholic fatty liver disease
(NAFLD), which is associated with negative epidemiological data on the prevalence of the …

Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study …

F Dashti, SM Alavian, AA Sohrabpour, SE Mousavi… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Non-alcoholic fatty liver disease (NAFLD) is a hepatic condition that is
considerably prevalent across the world. Dietary intakes, in which macronutrient …

Comparison of Ultrasound and Computed Tomography Findings in Non-Alcoholic Fatty Liver Disease in Obese and Non-obese Patients

N Mukhtar, A Yasin, A Tazeen, SMY Farooq… - Journal of Fatima …, 2023 - jfjmu.com
Background: Non-alcoholic fatty liver disease (NAFLD) affects 15 to 40% of people in
Western nations, 9 to 40% of people in Asian countries and 6-35% global incidence in …

THE THE MAIN CLINICAL AND PATHOGENETIC FEATURES OF THE COMORBID COURSE OF NON-ALCOHOLIC STEATOHEPATITIS, OBESITY AND …

ОС Хухліна, ОЄ Мандрик, ЗЯ Коцюбійчук… - Здобутки клінічної і … - ojs.tdmu.edu.ua
The incidence of nonalcoholic steatohepatitis (NASH) in the population is 20–40%, in obese
patients–50–90%. The presence of NASH significantly reduces the quality of life of patients …